LIVEKIDNEY.BIO
Regenerative Medicine Therapies for Kidney Disease
StartupLIVEKIDNEY.BIO is a Tel Aviv-Yafo-based startup in the Health Tech & Life Sciences sector, established in 2009. Regenerative Medicine Therapies for Kidney Disease. The company has raised a total of $4M across 1 funding round, currently at the Seed stage. Key investors include Aurum Ventures M.K.I, Jonathan Leitersdorf. The company has 1-10 employees. Core technologies: Biologicals, Cells, Artificial Intelligence.
With $4M in total funding, LIVEKIDNEY.BIO is a Seed-stage company operating in Health Tech & Life Sciences. The company follows a B2B business model. Product stage: Clinical Trial. The company holds 1 patent.
- StageSeed
- ProductClinical Trial
- ModelB2B
- Employees1-10
- HQTel Aviv-Yafo
- Last Round$4M
- Aurum Ventures M.K.I
- Jonathan Leitersdorf
2 articles covered by sources including www.israel21c.org,
en.globes.co.il.
What does LIVEKIDNEY.BIO do?
LIVEKIDNEY.BIO is a biotechnology company developing a proprietary cell-derived delivery platform that has the potential to improve the health and life of patients while reducing the escalating economic burden of kidney disease on society. Its technology is based on sustained-release hydrogel formulations combined with AI-enabled data analytics. The company’s novel AI-based cell-derived therapy is designed to ameliorate kidney function in patients with chronic kidney disease and to improve the general medical condition of patients with Lupus. Its promising pipeline of cell therapy-based products comprises proprietary injectable hydrogel formulations delivered via an exclusive administration route. LIVEKIDNEY.BIO aims to prevent the progression of kidney disease, enabling kidney patients to live longer, fuller, and more productive lives.
How much funding has LIVEKIDNEY.BIO raised?
LIVEKIDNEY.BIO has raised $4M in total funding across 1 rounds. The company is currently at the Seed stage. Key investors include Aurum Ventures M.K.I, Jonathan Leitersdorf.
What sector is LIVEKIDNEY.BIO in?
LIVEKIDNEY.BIO operates in Health Tech & Life Sciences, Pharma & Medical Biotechnology, Drugs Discovery & Development, with core technologies in Biologicals, Cells, Artificial Intelligence. Target customers: Healthcare & Life Sciences, Healthcare, Patients, Life Sciences, Biotechnology, Pharmaceuticals.
Where is LIVEKIDNEY.BIO located?
LIVEKIDNEY.BIO is based in Ahad Ha'Am St 9, Tel Aviv-Yafo, 6514224, Israel.